Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas

被引:35
|
作者
Abe, Masanobu
Westermann, Frank
Nakagawara, Akira
Takato, Tsuyoshi
Schwab, Manfred
Ushijima, Toshikazu
机构
[1] Univ Tokyo, Grad Sch Med, Natl Canc Ctr,Chuo Ku, Inst Res,Carcinogenesis Div, Tokyo 1040045, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Tokyo 1040045, Japan
[3] German Canc Res Ctr, Div Tumor Genet, D-6900 Heidelberg, Germany
[4] Chiba Canc Ctr, Inst Res, Div Biochem, Chiba, Japan
关键词
neuroblastoma; methylation; CIMP; MS-RDA; n-myc;
D O I
10.1016/j.canlet.2006.05.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The CpG island methylator phenotype (ClMP) was closely associated with poor overall survival (OS) in Japanese neuroblastoma (NBL) cases in our previous study. Here, in German NBL cases, CIMP(+) cases (n = 95) showed markedly poorer OS (hazard ratio (HR) = 9.5; P < 0.0001) and disease-free survival (DFS) (HR = 5.4; P < 0.0001) than CIMP(-) cases (n = 50). All the 23 cases with N-myc amplification had CIMP. Among the remaining cases without N-myc amplification, CIMP(+) cases (n 27) had a poorer OS (HR = 4.5; P = 0.02) and DFS (HR = 5.2; P < 0.0001) than CIMP(-) cases (n = 95). In multivariate analysis, CIMP and N-myc amplification had an influence on OS and DFS independent of age and disease stage. CIMP had a stronger influence on DFS than N-myc amplification while N-myc had a stronger influence on OS. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [1] Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas
    Kiyoshi Asada
    Masanobu Abe
    Toshikazu Ushijima
    Journal of Human Genetics, 2013, 58 : 428 - 433
  • [2] Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas
    Asada, Kiyoshi
    Abe, Masanobu
    Ushijima, Toshikazu
    JOURNAL OF HUMAN GENETICS, 2013, 58 (07) : 428 - 433
  • [4] Biological significance of the CpG island methylator phenotype
    Suzuki, Hiromu
    Yamamoto, Eiichiro
    Maruyama, Reo
    Niinuma, Takeshi
    Kai, Masahiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 455 (1-2) : 35 - 42
  • [5] Stronger Prognostic Power of the CpG Island Methylator Phenotype than Methylation of Individual Genes in Neuroblastomas
    Asada, Kiyoshi
    Watanabe, Naoko
    Nakamura, Yohko
    Ohira, Miki
    Westermann, Frank
    Schwab, Manfred
    Nakagawara, Akira
    Ushijima, Toshikazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (06) : 641 - 645
  • [6] CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas
    Abe, M
    Ohira, M
    Kaneda, A
    Yagi, Y
    Yamamoto, S
    Kitano, Y
    Takato, T
    Nakagawara, A
    Ushijima, T
    CANCER RESEARCH, 2005, 65 (03) : 828 - 834
  • [7] Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma
    An, CH
    Choi, IS
    Yao, JC
    Worah, S
    Xie, KP
    Mansfield, PF
    Ajani, JA
    Rashid, A
    Hamilton, SR
    Wu, TT
    CLINICAL CANCER RESEARCH, 2005, 11 (02) : 656 - 663
  • [8] Prognostic value of CpG island methylator phenotype in gastric cancer
    Xiao, Huashi
    Fu, Jiaxin
    Abe, Masanobu
    Ji, Jiafu
    Zong, Liang
    CANCER SCIENCE, 2018, 109 (08): : 2623 - 2625
  • [9] Status and Significance of CpG Island Methylator Phenotype in Endometrial Cancer
    Zhang, Qing-Ying
    Yi, De-Qing
    Zhou, Li
    Zhang, Dong-Hong
    Zhou, Tai-Mei
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2011, 72 (03) : 183 - 191
  • [10] Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma
    Koh, Young Wha
    Chun, Sung-Min
    Park, Young-Soo
    Song, Joon Seon
    Lee, Geon Kook
    Khang, Shin Kwang
    Jang, Se Jin
    TUMOR BIOLOGY, 2016, 37 (08) : 10675 - 10684